問卷

TPIDB > Principal Investigator

Principal Investigator


Taipei Veterans General Hospital (在職)

Division of Otolaryngology

Division of Radiation Therapy

Division of Hematology & Oncology

Taipei Medical University Hospital (在職)

Division of Infectious Disease

Division of Thoracic Medicine

Division of Hematology & Oncology

更新時間:2024-12-10

陳盛鈺Chen, Sheng-Yu
  • Principal Investigator
  • Clinical Trial Experience (year)
  • 211015@h.tmu.edu.tw

篩選

List

3Cases

2024-06-01 - 2027-12-31

Phase I

Active
  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Recruiting3Sites

2023-07-07 - 2026-07-31

Phase I

Active
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Recruiting5Sites

2023-07-07 - 2025-12-31

Phase I

A Global First-in-Human Study in NSCLC, HNSCC and Solid Tumors With ABBV-514 as a Single Agent and in Combination With Budigalimab
  • Condition/Disease

    Non-Small Cell Lung Cancer、 Head and Neck Squamous Cell Carcinoma

  • Test Drug

    ABBV-514ABBV-181 (Budigalimab)

Participate Sites
5Sites

Recruiting5Sites